Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 5/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23782857 | 0.96 | FBP1 (0.41) | FBP1L3MBTL1PDK1HTR7SMN1; SMN2 | |
| SCHEMBL30489039 | 0.96 | FBP1 (0.41) | FBP1L3MBTL1PDK1HTR7SMN1; SMN2 | |
| SCHEMBL6410067 | 0.92 | FBP1 (0.38) | FBP1L3MBTL1PDK1 | |
| SCHEMBL12468929 | 0.88 | FBP1 (0.41) | FBP1L3MBTL1PDK1HTR7SMN1; SMN2 | |
| SCHEMBL8619562 | 0.79 | FBP1 (0.39) | FBP1L3MBTL1PDK1HTR7SMN1; SMN2 | |
| SCHEMBL6036190 | 0.72 | ALDH1A1 (0.33) | L3MBTL1ALDH1A1TSHRHSD17B10 | |
| SCHEMBL8141739 | 0.70 | PDPK1 (0.40) | L3MBTL1ADORA2A | |
| SCHEMBL1771799 | 0.69 | — | — | |
| SCHEMBL577762 | 0.68 | NOS1 (0.36) | NOS1 | |
| SCHEMBL155319 | 0.68 | NOS1 (0.36) | SMN1; SMN2NOS1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1664 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116731293-A | Preparation method and application of benzo [1,2-b:4,5-b' ] dithiophene polymer containing asymmetric pi bridge | 江汉大学 | 2023-09-12 | — | — | CN | claimed |
| CN-114058224-B | Photo-thermal response super-hydrophobic anti-icing composite coating and preparation method thereof | 华南理工大学 | 2022-10-25 | — | — | CN | claimed |
| CN-114058224-A | Photo-thermal response super-hydrophobic anti-icing composite coating and preparation method thereof | 华南理工大学 | 2022-02-18 | — | — | CN | claimed |
| US-20260132126-A1 | IMIDAZOLE DERIVATIVES | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 2026-05-14 | — | — | US | disclosed |
| CN-122029166-A | Condensed cyclic compound and harmful arthropod control composition containing the same | 住友化学株式会社 | 2026-05-12 | — | — | CN | disclosed |
| US-20260108527-A1 | POLO LIKE KINASE 4 INHIBITORS | ORIC PHARMACEUTICALS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-12600732-B2 | Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway | NURIX THERAPEUTICS, INC. (US) | 2026-04-14 | — | — | US | disclosed |
| US-12583851-B2 | Heteroaryl-substituted pyrazine derivatives as pesticides | ELANCO ANIMAL HEALTH GMBH (DE) | 2026-03-24 | — | — | US | disclosed |
| US-20260078122-A1 | INDAZOLE COMPOUNDS AS PKMYT1 KINASE INHIBITORS | HOFFMANN-LA ROCHE INC. (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260078131-A1 | PYRROLO-PYRIDAZINE INHIBITORS OF JAK2 | AJAX THERAPEUTICS INC (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4709723-A1 | ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF | GENZYME CORPORATION (US) | 2026-03-18 | — | — | EP | disclosed |
| WO-1996033194-A1 | BENZIMIDAZOLE COMPOUNDS AND THEIR USE AS MODULATORS OF THE GABA A RECEPTOR COMPLEX | NEUROSEARCH A/S (DK) | 1996-10-24 | — | — | WO | disclosed |
| WO-1996033191-A1 | BENZIMIDAZOLE COMPOUNDS AND THEIR USE AS MODULATORS OF THE GABAA RECEPTOR COMPLEX | NEUROSEARCH A/S (DK) | 1996-10-24 | — | — | WO | disclosed |
| WO-1996026192-A1 | ISOXAZOLYL-BENZOYL DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 1996-08-29 | — | — | WO | disclosed |
| WO-1996026193-A1 | PHENYL DIKETONE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 1996-08-29 | — | — | WO | disclosed |
| WO-1996026206-A1 | PYRAZOL-4-YL-BENZOYL DERIVATIVES AND THEIR USE AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1996-08-29 | — | — | WO | disclosed |
| WO-1996026200-A1 | HERBICIDAL BENZOYL DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 1996-08-29 | — | — | WO | disclosed |
| WO-1996022292-A1 | TRICYCLIC VASOPRESSIN ANTAGONISTS | AMERICAN CYANAMID COMPANY (US) | 1996-07-25 | — | — | WO | disclosed |
| WO-1996020184-A1 | NAPHTHYL-BENZOXAZEPINES OR -BENZOTHIAZEPINES AS SQUALENE SYNTHETASE INHIBITORS | PFIZER INC. (US) | 1996-07-04 | — | — | WO | disclosed |
| US-5521173-A | TREATING DISEASES CHARACTERIZED BY EXCESS RENAL REABSORPTION OF WATER | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12583851-B2 | Heteroaryl-substituted pyrazine derivatives as pesticides | CBR3, CYCS, CWC15 | FBP1 2083/4885L3MBTL1 162/4885PDK1 3239/4885 |
| US-20260108527-A1 | POLO LIKE KINASE 4 INHIBITORS | PLK4, PLK2, PLK3 | FBP1 4049/4885L3MBTL1 2196/4885PDK1 702/4885 |
| US-20260078131-A1 | PYRROLO-PYRIDAZINE INHIBITORS OF JAK2 | JAK2, JAK1, JAK3 | FBP1 4091/4885L3MBTL1 3189/4885PDK1 1530/4885 |
| US-20260132126-A1 | IMIDAZOLE DERIVATIVES | ADRA1A, ADRA1D, ADRB1 | FBP1 1567/4885L3MBTL1 880/4885PDK1 2710/4885 |
| US-20260078122-A1 | INDAZOLE COMPOUNDS AS PKMYT1 KINASE INHIBITORS | PKN3, PKMYT1, IP6K3 | FBP1 1980/4885L3MBTL1 687/4885PDK1 378/4885 |
| US-12600732-B2 | Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway | BTK, BCL9, BCL9L | FBP1 3790/4885L3MBTL1 1491/4885PDK1 2926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.